UK markets open in 5 hours 30 minutes

ResMed Inc. (0KW4.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
183.77-0.03 (-0.02%)
At close: 05:18PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.67
52-week change 3-7.87%
S&P500 52-week change 325.01%
52-week high 3240.00
52-week low 30.00
50-day moving average 3181.11
200-day moving average 3176.89

Share statistics

Avg vol (3-month) 32.99k
Avg vol (10-day) 36.74k
Shares outstanding 5142.5M
Implied shares outstanding 6N/A
Float 8145.65M
% held by insiders 10.82%
% held by institutions 157.23%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.84
Trailing annual dividend yield 31.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2021
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 19.77%
Operating margin (ttm)29.18%

Management effectiveness

Return on assets (ttm)11.19%
Return on equity (ttm)21.66%

Income statement

Revenue (ttm)4.5B
Revenue per share (ttm)30.63
Quarterly revenue growth (yoy)12.50%
Gross profit (ttm)N/A
EBITDA 1.37B
Net income avi to common (ttm)890.39M
Diluted EPS (ttm)5.30
Quarterly earnings growth (yoy)-7.20%

Balance sheet

Total cash (mrq)217.86M
Total cash per share (mrq)1.48
Total debt (mrq)1.39B
Total debt/equity (mrq)31.04%
Current ratio (mrq)3.11
Book value per share (mrq)30.47

Cash flow statement

Operating cash flow (ttm)1.08B
Levered free cash flow (ttm)812.89M